---
layout: archive
title: "CV"
permalink: /cv/
author_profile: true
redirect_from:
  - /resume
---

{% include base_path %}

Education
======
* 2022-2024: **Doctoral thesis** (Magna cum laude)
    * Size of lymph-node metastases in prostate cancer patients undergoing radical prostatectomy
    * Prof. Lars Budäus, University of Hamburg, Hamburg, Germany
* 2012-2019: **Medical School** (final grade: excellent – "sehr gut")
    * Ruprecht Karl University, Heidelberg, Germany (clinical)
    * Hannover Medical School, Hannover, Germany (pre-clinical)


Work experience
======
* 2024-2025: **Post-doctoral research fellowship** (stipend)
  * Cancer Prognostics and Health Outcomes Unit
  * Centre Hospitalier de l'Université de Montréal, Montréal, Canada
  * Director: Prof. Pierre I. Karakiewicz

* 2021-2025: **Residency in Urology** 
  * Martini-Klinik Prostate Cancer Center 
  * University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  * Director: Prof. Markus Graefen

* 2021:	**Clinical fellowship**  
  * Section Translational Uro-Oncology
  * National Center for Tumor Diseases
  * German Cancer Research Center, Heidelberg, Germany
  * Director: Prof. Dirk Jäger

* 2019-2021: **Residency in Urology** 
  * Department of Urology
  * University Hospital of Heidelberg, Heidelberg, Germany
  * Director: Prof. Markus Hohenfellner

  
Awards
======
* 2024: **Best doctoral thesis**, North German Society of Urology
* 2023:	**Best poster**, German Association of Robotic Urology
* 2022-2023: **Scholarship for Interdisciplinary Oncology** by Medac GmbH


Peer Review
======
I have conducted peer-review for over 100 publications in following journals: Lancet Oncology, Nature Reviews Urology, European Urology Focus, European Urology Open Science, World Journal of Urology, BMC Urology, World Journal of Surgical Oncology, Scientific Reports, Complementary Medicine Research, European Journal of Medical Research, European Journal of Nuclear Medicine and Molecular Imaging, and PLOS ONE.

**Section Editor** for Current Opinion in Urology 2025 - Topic: biochemical recurrence of prostate cancer

Grants
======
* 2024 - German Cancer Aid:  Operative surgery-oriented research projects “Navigation, outcomes and quality of life in prostate cancer patients after PSMA-targeted surgery” (NICE-PSMA)
